Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
EUROGIN 2008 - 8th International Multidisciplinary Congress
Global Health and the Human Papillomavirus Vaccine
Nice, France / November 12-15, 2008
Nice - Sustained protection against the burden of disease related to infection with the human papillomavirus (HPV) types 6, 11, 16 and 18 continues to be reported with the quadrivalent vaccine. The vaccine has been found to prevent...
PRIORITY PRESS - Critical Care Canada Forum
Echinocandins in the ICU: A Clinical Advance
Toronto, Ontario / November 11-13, 2008
Invasive and septic Candida infections are associated with high levels of mortality and morbidity. However, the agents most commonly used to empirically treat these pathogens are associated with significant drawbacks: there are now high...
PRIORITY PRESS - 9th International Congress on Drug Therapy in HIV Infection (HIV9)
Landmark MOTIVATE Trial: Analysis of Latest Findings
Glasgow, Scotland / November 9-13, 2008
Dr. David Hardy, Director Divison of Infectious Diseases, Cedars-Sinai Medical Center, Los Angeles, California, detailed the 96-week data from the randomized, double-blind placebo-controlled phase IIb and III ‘Maraviroc vs. Optimized...
MEDICAL FRONTIERS - 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Annual Meeting of the Infectious Diseases Society of America (IDSA)
Strategies to Improve Treatment Success of Gram-negative Infections
Washington, DC / October 25-28, 2008
Washington, DC - Multidrug-resistant organisms, particularly extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae, are becoming a worldwide problem. The proportion of ESBL-producing pathogens is on the rise and the odds of...
48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Disease Society of America 46th Annual Meeting
MRSA Management: From Prevention to Treatment
Washington, DC / October 25-28, 2008
Washington, DC - Methicillin-resistant Staphylococcus aureus (MRSA) is widely recognized as one of the world’s most prevalent pathogens presenting an imminent threat in the health care and community setting. This has made it the focus of...
PRIORITY PRESS - 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America 46th Annual Meeting
Combatting the Increasing Prevalence of Hospital-acquired and Community-acquired Pneumonias
Washington, DC / October 25-28, 2008
In recent years, rates of infection with methicillin-resistant Staphylococcus aureus (MRSA) have grown substantially. In addition, MRSA is no longer confined to the hospital or institutional setting, and community-acquired (CA)-MRSA...
MEDICAL FRONTIERS - 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America 46th Annual Meeting (IDSA)
Echinocandins in Invasive Fungal Disease: Prophylaxis and Empiric Therapy
Washington, DC / October 25-28, 2008
Invasive fungal infections represent important causes of morbidity and mortality in multiple patient populations, including those with neutropenia who receive chemotherapy for cancer or who undergo hematopoietic stem-cell transplant (HSCT)....
PRIORITY PRESS - 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious Diseases Society of America
MERIT Re-evaluation: Impact of an Enhanced Sensitivity Tropism Assay
Washington, D.C./ October 25-28, 2008
The ability to detect CXCR4-using minor variants of HIV in HIV-infected patients is paramount to identifying those patients with a low likelihood of responding to CCR5 co-receptor antagonists. As the first approved agent in this class,...
NEW FRONTIERS - 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Annual Meeting of the Infectious Disease Society of America
Effective HIV Suppression and Simplified HIV Therapy: Not Mutually Exclusive Clinical Goals
Washington, DC / October 25-28, 2008
The ACTG5202 trial looking at the safety and efficacy of four different highly-active antiretroviral therapy (HAART) regimens in treatment-naïve HIV-infected adults raised questions about the comparative efficacy of regimens containing...